MRMD News and Press, MariMed Inc From 05/10/22

Revenue Grew 27% Year Over Year Non-GAAP Adjusted EBITDA Grew 29% Year Over Year Company Maintains Full Year 2022 Guidance NORWOOD, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”),...

MariMed (OTCQX:MRMD) is scheduled to announce Q1 earnings results on Tuesday, May 10th, after market close. The consensus EPS Estimate is $0.01 and the consensus Revenue Estimate is $30M (+22.0% Y/Y). Contributor rating on the stock by contributor who writes: 'MariMed CEO Bob Fireman - Revenu...

NORWOOD, Mass., May 05, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced it has closed its acquisition of Green Growth Group, Inc. (&#x...

NORWOOD, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced its participation in the following upcoming conferences: ...

NORWOOD, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced it completed the acquisition of Kind Therapeutics U.S.A., LLC...

NEW YORK, April 26, 2022 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated financial markets for 12,000 U.S. and global securities, today announced the first quarter 2022 performance and quarterly rebalancing of the OTCQX® and OTCQB® indexes, incl...

MariMed (OTCQX:MRMD) said the Maryland Medical Cannabis Commission approved the transfer of 100% of the ownership of cannabis company Kind Therapeutics U.S.A. to MariMed. In January, MariMed said it was acquiring Kind for $20M, which is to be paid via a combination of cash...

NORWOOD, Mass., April 14, 2022 (GLOBE NEWSWIRE) -- MariMed Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced that the Maryland Medical Cannabis Commission (MMCC) has appr...

NORWOOD, Mass., April 12, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced it will report its first quarter 2022 financial results for ...

Jon DeCourcey from Viridian Capital Advisors returns to discuss recent earnings in the cannabis space and why disappointment is overblown. Favoring quality, underappreciated names due to favorable fundamentals and growth opportunities. The interesting way institutional capital is ...